Back
Nuvalent Vs. Pfizer Industry Stock Comparison
Sell
50
NUVL
Nuvalent
Last Price:
$77.98
Seasonality Move:
37.69%
Buy
53
PFE
Pfizer
Last Price:
$24.85
Seasonality Move:
0.13%
Sell
50
Nuvalent (NUVL)
is a Sell
Is Nuvalent a Buy, Sell or Hold?
-
NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUVL Stock Price Chart
NUVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 56.36 | Buy |
Chaikin Money Flow: | 105866 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.82 - 77.24) | Buy |
Bollinger Bands (100): | (69.59 - 81.05) | Buy |
PFE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 65.94 | Buy |
Chaikin Money Flow: | 32759041 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.69 - 23.91) | Buy |
Bollinger Bands (100): | (22.96 - 26.16) | Buy |
NUVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.68 | Buy |
20-day SMA: | 75.28 | Buy |
50-day SMA: | 72.41 | Buy |
200-day SMA: | 83.44 | Sell |
8-day EMA: | 77.25 | Buy |
20-day EMA: | 75.74 | Buy |
50-day EMA: | 74.51 | Buy |
200-day EMA: | 77.64 | Buy |
PFE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.85 | Buy |
20-day SMA: | 23.47 | Buy |
50-day SMA: | 23.11 | Buy |
200-day SMA: | 26.09 | Sell |
8-day EMA: | 24.05 | Buy |
20-day EMA: | 23.63 | Buy |
50-day EMA: | 23.68 | Buy |
200-day EMA: | 25.66 | Sell |
Nuvalent Earnings Growth & NUVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, an increase next quarter of $0.33 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.03 per share.
Pfizer Earnings Growth & PFE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.27 per share, an increase this year of $0.07 per share, and an increase next year of $0.09 per share.
Nuvalent Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pfizer Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |